Your browser is no longer supported. Please, upgrade your browser.
Settings
TROV TrovaGene, Inc. daily Stock Chart
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own0.80% Shs Outstand29.62M Perf Week18.10%
Market Cap187.49M Forward P/E- EPS next Y-1.29 Insider Trans198.35% Shs Float26.85M Perf Month-15.60%
Income-27.40M PEG- EPS next Q-0.28 Inst Own30.30% Short Float12.06% Perf Quarter-44.18%
Sales0.30M P/S624.98 EPS this Y-8.60% Inst Trans28.80% Short Ratio4.21 Perf Half Y0.64%
Book/sh0.74 P/B8.55 EPS next Y1.50% ROA-72.80% Target Price10.50 Perf Year12.23%
Cash/sh1.39 P/C4.54 EPS next 5Y- ROE-176.30% 52W Range4.00 - 13.58 Perf YTD47.21%
Dividend- P/FCF- EPS past 5Y-9.20% ROI-63.90% 52W High-53.39% Beta-0.96
Dividend %- Quick Ratio8.40 Sales past 5Y-15.60% Gross Margin0.00% 52W Low58.25% ATR0.63
Employees31 Current Ratio8.40 Sales Q/Q-11.30% Oper. Margin- RSI (14)47.20 Volatility10.38% 11.32%
OptionableYes Debt/Eq0.84 EPS Q/Q-78.30% Profit Margin- Rel Volume0.77 Prev Close5.72
ShortableYes LT Debt/Eq0.71 EarningsAug 10 AMC Payout- Avg Volume768.12K Price6.33
Recom1.50 SMA205.20% SMA50-20.48% SMA200-13.55% Volume590,702 Change10.66%
Aug-14-15Initiated Leerink Partners Outperform
Apr-20-15Reiterated Maxim Group Buy $10 → $13
Jul-10-14Initiated Maxim Group Buy $10
Nov-13-13Reiterated Aegis Capital Buy $14 → $10
Oct-01-13Reiterated Aegis Capital Buy $14
Jul-16-13Initiated Cantor Fitzgerald Buy $10
Apr-01-13Reiterated Aegis Capital Buy $12 → $14
Dec-12-12Initiated Aegis Capital Buy $12
Aug-22-15 01:04PM  TROVAGENE, INC. Financials
Aug-18-15 11:29AM  TROVAGENE, INC. Files SEC form 8-K, Other Events -6.47%
08:05AM  Trovagene to Present Clinical Data and Capabilities of Its Urine-Based Liquid Biopsy Platform at the 7th Annual Next Generation Dx Summit PR Newswire
Aug-14-15 09:18AM  Leerink: Trovagene Is A Pure Play That Should Outperform
07:08AM  Coverage initiated on TrovaGene by Leerink Partners
Aug-13-15 09:40AM  Insiders Are Buying Up Shares Of Sothebys (BID), Summit Hotel Properties Inc (INN), and TrovaGene Inc (TROV) at Insider Monkey
Aug-12-15 12:50PM  Psychemedics Corp. Earnings Q2*, 2015 +10.52%
Aug-11-15 09:00AM  TrovaGene Q2 Loss Widens on Higher Expenses, Shares Fall - Analyst Blog -13.69%
Aug-10-15 10:06PM  Edited Transcript of TROV earnings conference call or presentation 10-Aug-15 9:00pm GMT
06:13PM  Trovagene reports 2Q loss
04:14PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:09PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  Trovagene, Inc. Announces Second Quarter 2015 Financial Results PR Newswire
07:07AM  Q2 2015 Trovagene Inc Earnings Release - 4:00 pm ET
Aug-07-15 03:40PM  TrovaGene (TROV): What???s in Store this Earnings Season? - Analyst Blog
Jul-23-15 11:49AM  5 Health Care Stocks Under $10 Set to Soar at TheStreet -5.82%
10:30AM  Bridger Management Inceases Its Stake In TrovaGene Inc. (TROV) Via Its SPO at Insider Monkey
08:15AM  Trovagene Schedules Release of Second Quarter 2015 Financial Results and Investor Conference Call PR Newswire
Jul-22-15 04:16PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +6.87%
10:12AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
Jul-17-15 03:22PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -9.28%
03:16PM  TrovaGene (TROV) Stock Tanks After Pricing Secondary Offering at TheStreet
09:00AM  Trovagene, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire
Jul-16-15 04:48PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:29PM  Trovagene, Inc. Announces Public Offering of Common Stock PR Newswire
Jul-09-15 01:40PM  Trovagene's PCM to Monitor Melanoma Patients in New Study - Analyst Blog
Jul-08-15 09:49AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:10AM  Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform PR Newswire
Jul-07-15 12:02PM  TROVAGENE, INC. Files SEC form 8-K, Other Events -5.25%
08:05AM  Trovagene Inc. to Present at Cantor Fitzgerald's Inaugural Healthcare Conference PR Newswire
Jul-06-15 11:10AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.98%
Jun-29-15 10:08AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes PR Newswire
Jun-26-15 09:45AM  Four Small Cap Stocks Overlooked by Wall Street Accesswire
Jun-25-15 06:40PM  WRLD, TROV, MEI: Biggest Losers Of The Day And What Hedge Funds Think About Them at Insider Monkey -12.49%
Jun-17-15 07:00AM  FPMI Trades At An 80 Percent Discount to Fair Value with Major Catalyst Looming
Jun-11-15 09:05AM  TrovaGene (TROV) Shares March Higher, Can It Continue? - Tale of the Tape +6.92%
Jun-10-15 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
09:50AM  TrovaGene Hits 52-Week High, PCM Continues to Impress - Analyst Blog
Jun-08-15 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences PR Newswire
Jun-05-15 07:32PM  Lightning Round: It's linked to China & troubled at CNBC
May-28-15 08:43AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:05AM  Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting PR Newswire
May-19-15 09:20AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-13-15 05:21PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:01PM  Clinical Utility of Trovagene's Urine-Based Liquid Biopsy Platform to Be Highlighted at the American Society of Clinical Oncology Meeting PR Newswire
May-12-15 09:46AM  TrovaGene (TROV) in Focus: Stock Rises 7.1% - Tale of the Tape
May-08-15 12:14PM  TrovaGene, Inc. Earnings Analysis: By the Numbers +5.39%
May-06-15 09:36AM  TrovaGene (TROV) Q1 Loss Wider than Expected, Shares Plunge - Analyst Blog +15.66%
May-05-15 06:44PM  Trovagene, Inc. Announces First Quarter 2015 Financial Results at noodls -5.28%
05:37PM  Trovagene reports 1Q loss
04:35PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:14PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Trovagene, Inc. Announces First Quarter 2015 Financial Results PR Newswire
07:07AM  Q1 2015 Trovagene Inc Earnings Release - 4:00 pm ET
May-04-15 10:04AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:23AM  Cost Benefit Analysis of Trovagene's Precision Cancer Monitoring Solution to Be Presented at the Association for Value-Based Cancer Care in Washington, DC at noodls
08:00AM  Cost Benefit Analysis of Trovagene's Precision Cancer Monitoring Solution to Be Presented at the Association for Value-Based Cancer Care in Washington, DC PR Newswire
May-01-15 11:55AM  Is it a Miss for TrovaGene (TROV) This Earnings Season? - Analyst Blog +9.81%
Apr-28-15 01:26PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:00AM  Trovagene Schedules Release of First Quarter 2015 Financial Results and Investor Conference Call PR Newswire
Apr-23-15 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:09AM  Trovagene's Urine-Based HPV Assay to Be Featured in Presentation at the 13th Annual Cervical Cancer Conference and HPV Consortium in Beijing at noodls
08:00AM  Trovagene's Urine-Based HPV Assay to Be Featured in Presentation at the 13th Annual Cervical Cancer Conference and HPV Consortium in Beijing PR Newswire
Apr-20-15 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
03:08PM  TrovaGene's (TROV) PCM Data Impresses, Shares Rally - Analyst Blog
08:21AM  Poster Presentations at 2015 AACR Annual Meeting to Highlight Clinical Utilities and Advantages of Trovagene's ctDNA Precision Cancer Monitoring Platform at noodls
08:00AM  Poster Presentations at 2015 AACR Annual Meeting to Highlight Clinical Utilities and Advantages of Trovagene's ctDNA Precision Cancer Monitoring Platform PR Newswire
Apr-17-15 10:45AM  Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients at noodls +20.14%
10:30AM  Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients PR Newswire
Apr-04-15 09:25AM  4 Fresh Biotech Stock Picks With Targets 50% to 100% Higher at 24/7 Wall St.
Mar-18-15 11:59AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:03AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer at noodls
08:31AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer PR Newswire
08:20AM  TrovaGene (TROV) Enters Overbought Territory - Tale of the Tape
Mar-17-15 08:37AM  TrovaGene (TROV) in Focus: Stock Adds 6.1% in Session - Tale of the Tape +8.30%
Mar-13-15 09:40AM  TrovaGene (TROV) Posts Wider Q4 Loss on Higher Expenses - Analyst Blog
Mar-12-15 07:04PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results at noodls
05:36PM  Trovagene reports 4Q loss
04:19PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:05PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Mar-10-15 04:52PM  What's in Store for TrovaGene (TROV) for Earnings Season? - Analyst Blog
Mar-03-15 12:16PM  TrovaGene Inc (TROV) Sees Bridger Management Buy More Shares; Other Stocks Roberto Mignone Loves at Insider Monkey +5.12%
Feb-26-15 05:51PM  Trovagene Schedules Release of Fourth Quarter and Year End 2014 Financial Results and Investor Conference Call at noodls +6.74%
04:05PM  Trovagene Schedules Release of Fourth Quarter and Year End 2014 Financial Results and Investor Conference Call PR Newswire
Feb-11-15 11:40AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:11AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock at noodls
10:12AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
Feb-10-15 08:05AM  Trovagene, Inc. to Present at Leerink Global Healthcare Conference PR Newswire +5.93%
Feb-09-15 12:46PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions PR Newswire
Feb-06-15 02:46PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online -23.59%
12:57PM  TrovaGene Falls Sharply; Prices Offering Below Expectations Benzinga
08:27AM  Trovagene, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire
Feb-05-15 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:09PM  Trovagene, Inc. Announces Public Offering of Common Stock PR Newswire
Jan-29-15 01:06PM  3 Biotech Stocks Under $10 in Breakout Territory: TrovaGene and More at TheStreet
Jan-26-15 12:00PM  TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog Zacks
11:55AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It is developing PCM BRAF and KRAS mutation detection tests for detecting mutations in metastatic cancer patients; and HPV HR detection test to detect the presence of various HPV genotypes using a urine sample. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tennant StanleyDirectorAug 12Buy6.0610,00060,600192,762Aug 12 04:50 PM
SCHUH ANTONIUSCEOAug 12Buy5.4520,000109,00020,000Aug 12 04:35 PM
BRIDGER MANAGEMENT, LLC10% OwnerJul 17Buy8.75140,0001,225,0003,290,587Jul 21 05:27 PM
BRIDGER MANAGEMENT, LLC10% OwnerApr 02Buy6.90300,0002,070,0003,150,587Apr 06 05:00 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 27Buy5.6279,343445,9082,850,587Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 26Buy5.4278,801427,1012,771,244Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 25Buy5.12105,142538,3272,692,443Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 06Buy4.50444,4441,999,9982,587,301Feb 10 04:25 PM